Introduction
============

T~regs~ are crucial in maintenance of self-tolerance and immune homeostasis. Mice that lack T~regs~ suffer from severe autoimmune and inflammatory conditions \[[@B1], [@B2]\]. In humans, T~regs~ isolated from cord blood, thymus, and peripheral blood suppress proliferation and cytokine production of other T cells in response to self and environmental antigens \[[@B3]--[@B5]\]. T~regs~ are found within the CD4^+^CD25^+^ T cell population and express high levels of the transcription factor FOXP3 \[[@B6]\]. Children born with a dysfunctional *foxp3* gene develop immunodysregulation, polyendocrinopathy, enteropathy, X-linked/X-linked autoimmune-allergic dysregulation, a syndrome characterized by organ-specific autoimmune diseases, severe dermatitis, and enterocolitis with food allergy \[[@B7], [@B8]\]. In adults, a majority of FOXP3^+^ T~regs~ expresses intracellular CTLA-4 \[[@B9]\], which has been proven to be essential for T~regs~ to control activation and expansion of other T cells \[[@B10]--[@B14]\]. The importance of CTLA-4 in immune regulation is also shown in CTLA-4-deficient mice that develop a fatal autoimmune disorder, characterized by infiltration of CD4^+^ T cells in several nonlymphoid tissues \[[@B15], [@B16]\]. Not only FOXP3^+^ T~regs~ but also newly activated CD4^+^ T cells express CTLA-4, and these cells have been shown to have regulatory functions in vitro \[[@B13]\]. Furthermore, CTLA-4 expressed in non-T~regs~ prevents the migration and accumulation of autoantigen-specific T cells into target tissue in mice \[[@B14], [@B17]\]. It was demonstrated recently that CTLA-4, expressed on T~regs~ or non-T~regs~, captures CD80 or CD86 on APCs by transendocytosis, a process that prevents T cell activation \[[@B18]\]. Although FOXP3 and CTLA-4 expression in CD4^+^CD25^+^ T cells have been widely studied in adults, it is not known how these two markers are expressed during postnatal development of the immune system.

The trafficking of lymphocytes depends on interactions between tissue-specific chemokines and endothelial adhesion molecules and the corresponding receptors on the lymphocyte subsets. In humans, naïve CD45RA^+^ T cells express the homing receptors CD62L and CCR7 and in infants, also α~4~β~7~ \[[@B19]--[@B21]\]. These homing receptors allow the naïve T cell to enter the secondary lymphoid tissue to be activated \[[@B20]--[@B22]\]. In contrast, memory CD45RO^+^ T cells display a homing receptor phenotype depending on the site of activation \[[@B19], [@B23]\]. Thus, T cells activated in LNs draining the skin will express the homing receptor CCR4 \[[@B24]\], whereas T cells activated in gut-associated lymphoid tissue will express the homing receptors α~4~β~7~ and CCR9 \[[@B25]\]. The homing phenotype may be used as a differentiation marker in CD4^+^ T cells, as we showed recently that CD4^+^CD25^+^ T cells undergo homing receptor switch, i.e., from being α~4~β~7~-positive to be CCR4-positive, which coincides with their differentiation from a naïve to a memory phenotype \[[@B26]\]. Yet, it remains to be determined whether FOXP3^+^ or CTLA-4^+^ T~regs~ early in life are associated with naïve or memory CD4^+^ T cells later in life.

To address these issues, we have examined blood lymphocytes from a prospectively followed newborn-infant cohort of 65 infants regarding the proportion of the CD4^+^CD25^+^ T cell subsets that expresses intracellular FOXP3 or CTLA-4 and the expression of naïve and memory markers (CD45RA and CD45RO) and homing receptors (α~4~β~7~, CD62L, and CCR4) on CD4^+^ T cells. For the first time, we show that high percentages of FOXP3^+^ or CTLA-4^+^ T~regs~ within the CD4^+^CD25^+^ T cell population in infants are negatively associated with the expression of the memory markers CD45RO and CCR4 on circulating CD4^+^ T cells later in childhood using multivariate factor analysis. Thus, our results indicate that a high proportion of FOXP3^+^ and CTLA-4^+^ T~regs~ early in infancy may modulate the proportion of memory CD4^+^ T cells later in life.

MATERIALS AND METHODS
=====================

Subjects and collection of blood samples
----------------------------------------

Blood samples were collected from a prospective newborn-infant cohort, aiming at investigating the maturation of the immune system. The study included 65 healthy infants (33 boys and 32 girls), born at term (≥38 gestational weeks) in rural areas of Southwest Sweden. Cord blood samples were obtained at birth from 48 infants, and peripheral blood samples were obtained at 3--5 days (*n*=59), 1 month (*n*=59), 4 months (*n*=58), 18 months (*n*=63), and 36 months (*n*=50) of age. For simultaneous staining for FOXP3 and CTLA-4, cord blood was obtained from healthy newborn infants born at term at the Sahlgrenska University Hospital/Mölndal (Gothenburg, Sweden). Peripheral blood was also obtained from 20 healthy adult volunteers aged 25--55 years. All blood samples were collected in preservative-free heparin tubes. Informed consent was obtained from the parents and volunteers, and the study was approved by the Human Research Ethics Committee of the Medical Faculty, University of Gothenburg (Sweden).

Flow cytometry
--------------

Phenotypic analysis of T lymphocytes was performed by flow cytometry within 72 h of venepuncture. Initial experiments showed that proportions and numbers of different lymphocyte populations were unaffected by 72-h storage in room temperature compared with freshly isolated samples (data not shown). Whole blood (50 μl/tube for surface staining or 100 μl/tube for surface and intracellular staining) was incubated for 20 min at 4°C with the following antihuman mAb: allophycocyanin-conjugated anti-CD25 (clone 2A3; BD Biosciences, Erembodegem, Belgium); FITC-conjugated anti-CD45RA (clone L48; BD Biosciences), anti-CD62L (clone Dreg-56; BD Biosciences), and anti-CD49d (clone 44H6; Serotec, UK); PerCP-conjugated anti-CD4 (clone SK3; BD Biosciences); and PE-conjugated anti-CD45RO (clone UCHL-1; BD Biosciences), anti-β7-integrin (clone FIB504; BD Biosciences), and anti-CCR4 (clone IG1; BD Biosciences). RBCs were then lysed (FACS lysing solution, BD Biosciences), and the remaining cells were washed twice with FACS buffer. After completed cell-surface staining, the cells were intracellularly stained for FOXP3 or CTLA-4. Fixation, permeabilization, and staining for FOXP3 were performed using the kit PE-antihuman FOXP3 staining set (eBioscience, San Diego, CA, USA), whereas for CTLA-4, fixation and permeabilization were performed using the Cytofix/Cytoperm kit (BD Biosciences), followed by staining with biotin-conjugated CTLA-4 (clone BNI3; BD PharMingen, San Diego, CA, USA), followed by PE-conjugated streptavidin (BD Biosciences), according to the manufacturer\'s instructions. Moreover, simultaneous staining for intracellular FOXP3 and CTLA-4 in the CD4^+^CD25 T cell population was performed on cells from newborn children, 36-month-old children, and adults. Peripheral mononuclear cells were isolated by density gradient centrifugation using Lymphoprep (Nycomed, Oslo, Norway). The cells were stained with Horizon V450-conjugated anti-CD4 (clone RPA-T4; BD Biosciences) and allophycocyanin-conjugated anti-CD25 for 20 min at 4°C in the dark. Thereafter, permeabilization and staining were performed using the kit PE-antihuman FOXP3 staining set, followed by staining with PE-conjugated FOXP3 (clone PCH101; eBioscience) and biotin-conjugated CTLA-4 (clone BNI3; BD PharMingen), followed by PE-Cy7-conjugated streptavidin (BD Biosciences). All isotype controls were purchased from BD Biosciences, except for the isotype control for FOXP3, which was purchased from eBioscience. A FACSCanto II (BD Biosciences), equipped with FACSDiva software, was used to analyze the simultaneous staining for CTLA-4 and FOXP3. All other stainings were analyzed on a FACSCalibur (BD Biosciences) equipped with CellQuestPro software. All flow cytometry data were analyzed using Flow Jo software (Tree Star, Ashland, OR, USA). FOXP3^+^ T~regs~ and CTLA-4^+^ T cells, within the CD4^+^CD25^+^ and CD4^+^CD25^high^ T cell populations, were defined by the procedure shown in Supplemental Fig. 1: based on the expression CD25 on CD4^+^ T cells, three gates were set to identify CD25^−^, CD25^+^, and CD25^high^ T cells (2% of the CD4^+^ T cells that expressed high CD25). The gate for FOXP3 and CTLA-4 were set by comparing the expression of FOXP3 or CTLA-4 within the CD25^−^, CD25^+^, or CD25^high^ populations with each other and their isotype controls. The expression of FOXP3, CTLA-4, CD45RA, and CD45RO was analyzed at birth, 3--5 days, and 1, 4, 18, and 36 months, whereas the expression of HLA-DR, α~4~β~7~, CD62L, and CCR4 was analyzed at birth and 4, 18, and 36 months of age.

Statistical analysis
--------------------

The relationship among the different T cell subsets at different ages was analyzed using the multivariate factor analyses: PCA and OPLS (SIMCA-P+ software version 12, Umetrics, Umeå, Sweden). PCA, including data for each individual, was first performed, as it generates hypotheses by providing an overview of groupings and trends and makes it possible to detect possible outliers regarding the CD4^+^ T cell naïve and memory phenotype, homing receptor expression, and the proportions of circulating FOXP3^+^ or CTLA-4^+^T~regs~. The quality of the PCA was assessed based on the parameters R2 and Q2, i.e., the percentages of the variation of the dataset explained (R2) and predicted (Q2) by the model, respectively. OPLS is a regression development of PCA, which was implemented to correlate the X and Y data matrices, where X represents expression of memory markers and homing receptors for each individual, and Y represents the fraction of FOXP3^+^ or CTLA-4^+^T~regs~ for each subject. The generated OPLS model correlates the X matrices with Y using a linear multivariate model. The importance of each X variable to Y is represented by column bars. Jack-knifing was used to calculate standard errors displayed as error bars on each column (representing the 95% confidence interval). Univariate correlation tests were only performed between the proportions of FOXP3^+^ or CTLA-4^+^T~regs~ and the X variables (naïve, memory, and homing markers), which contributed most to Y, i.e., variables that displayed large bars with error bars not crossing the *x*-axis in the OPLS analysis. Univariate data analysis, including Spearman\'s rank correlation test, Kruskal-Wallis test followed by Dunn\'s multiple comparison test or Mann-Whitney U test (GraphPad Prism, GraphPad Software, San Diego, CA, USA), was used as described in the figure legends. *P* ≤ 0.05 was considered as significant (\**P*≤0.05; \*\**P*≤0.01; and \*\*\**P*≤0.001).

RESULTS
=======

Proportions of FOXP3^+^ T~regs~ and CTLA-4^+^ T cells during infancy and in adults
----------------------------------------------------------------------------------

We analyzed the proportion of FOXP3^+^ T~regs~ and CTLA-4^+^ T cells within the CD4^+^CD25^+^ (CD25^+^) T cell population at birth, 3--5 days, and 1, 4, 18, and 36 months of age and compared them with adults. As shown in **[Fig. 1](#F1){ref-type="fig"}A** and **B**, the proportion of FOXP3^+^ T~regs~ displayed a striking rise between birth and 3--5 days of age, but during the following 18 months, no further increase occurred. The proportion of CTLA-4, on the other hand, remained constant during the first 18 months of life. However, at 36 months of age, the fractions of FOXP3^+^ T~regs~ and CTLA-4^+^ T cells were significantly lower than that observed at 4 months of age ([Fig. 1](#F1){ref-type="fig"}A and B; regarding FOXP3, all data at birth, 3--5 days, 1 and 4 months, as well as part of the 18-month data have been published previously by Grindebacke et al. \[[@B26]\]). The increase of the proportion of FOXP3^+^ T~regs~ between birth and 3--5 days of age was not a result of an increment in the total CD25^+^ T cell count, as the total numbers of CD25^+^ T cells did not rise during the first week of life, as demonstrated in [Fig. 1](#F1){ref-type="fig"}C.

![The proportion of circulating FOXP3^+^ T~regs~ and CTLA-4^+^ T cells during the first 36 months of life.\
The proportion of circulating CD4^+^CD25^+^ T cells that expresses (A) FOXP3 (FOXP3^+^ T~regs~) or CTLA-4 (CTLA-4^+^ T cells) at birth (Cord), 3--5 days, and 1, 4, 18, and 36 months and in adults. Regarding FOXP3^+^ T~regs~, all data at birth, 3--5 days, and 1 and 4 months of age and in adults, as well as part of the 18-month data, have been published previously by Grindebacke et al. \[[@B26]\]. (B) Representative dot plots showing FOXP3^+^ T~regs~ and CTLA-4^+^ T cells at birth, 4 months, and 36 months of age. (C) Absolute count of CD4^+^ CD25^+^ T cells at birth, 3--5 days, and 1, 4, 18, and 36 months and in adults. Each symbol represents one individual, and horizontal bars indicate the median value. (D) Representative dot plots showing the coexpression of FOXP3 and CTLA-4 in CD4^+^CD25^+^ T cells at birth and 36 months of age and in adults. Numbers represent the percentage of cells within the gate. \**P* ≤ 0.05; \*\**P* ≤ 0.01; and \*\*\**P* ≤ 0.001 (Kruskal-Wallis test followed by Dunn\'s multiple comparison test).](zgb9990955070001){#F1}

To examine whether FOXP3 and CTLA-4 were coexpressed on the same CD25+ T cells, we simultaneously stained the cells with these two markers ([Fig. 1](#F1){ref-type="fig"}D). However, intracellular double-staining for FOXP3 and CTLA-4 quenched each other, making it difficult to gate properly. Accordingly, the data from double-stained samples were not consistent with the data from single-stained samples. Therefore, single-stained FOXP3^+^ or CTLA-4^+^ T cells within the CD25^+^ T cell population were used to study the relationship between T~regs~ and naïve or memory T cells.

Relationship between FOXP3^+^ or CTLA-4^+^ T~regs~ and the expression of memory markers and homing receptors on circulating CD4^+^ T cells during infancy
---------------------------------------------------------------------------------------------------------------------------------------------------------

We first examined the proportions of CD4^+^ T cells that expressed CD45RA (naïve T cells), CD45RO (memory T cells), HLA-DR, α~4~β~7~, CCR4, or CD62L in blood samples obtained at birth, 3--5 days, and 1, 4, 18, and 36 months of age using flow cytometry. As shown in **[Fig. 2](#F2){ref-type="fig"}A--G**, the proportions of naïve CD45RA^+^, α~4~β~7~^+^, or CD62L^+^ T cells decreased significantly with age, whereas the proportions of memory or activated CD4^+^ T cells, which expressed CD45RO, HLA-DR, or CCR4, increased with age (Kruskal-Wallis test followed by Dunn\'s multiple comparison test). We found a large individual variation in the proportions of CD4^+^ T cells that expressed CD45RA, CD45RO, α~4~β~7~, CD62L, or CCR4 ([Fig. 2](#F2){ref-type="fig"}A--E and G).

![Percentages of circulating CD4^+^ T cells that express CD45RA, CD45RO, HLA-DR, α~4~β~7~, CCR4, or CD62L during the first 36 months of life.\
The percentage of circulating CD4^+^ that express (A) CD45RA, (B) CD45RO, (C) α~4~β~7~, (D) CCR4, (E) CD62L, or (F) HLA-DR at different time-points during the first 36 months of life. Each symbol represents one individual, and horizontal bars indicate the median value. (G) Representative dot plots showing CD45RA^+^, CD45RO^+^, α4β7^+^ (CD49d^+^β7^+^), CCR4^+^, CD62L^+^, and HLA-DR^+^ cells within the CD4^+^ T cell population at 4 and 36 months of age. Numbers represent the percentage of cells within the gate. \**P* ≤ 0.05; \*\**P* ≤ 0.01; and \*\*\**P* ≤ 0.001 (Kruskal-Wallis test followed by Dunn\'s multiple comparison test).](zgb9990955070002){#F2}

Next, we examined whether FOXP3^+^ or CTLA-4^+^ T~regs~ within the CD25^+^ T cell population were related to CD4^+^ T cells that expressed CD45RA, CD45RO, HLA-DR, α~4~β~7~, CCR4, or CD62L using multivariate factor analysis. To examine these relationships, we used the proportions of the different T cell subtypes, as absolute cell counts were dependent on the absolute number of the CD4^+^ T cells (data not shown). PCA was first performed to obtain an overview of how the different variables related to one another \[[@B27]\]. As depicted in the score scatter plots, we found that the proportions of CD4^+^ T cells that expressed CD45RA, α~4~β~7~, or CD62L and the proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ within the CD25^+^ T cell population were all projected on one side of the *x*-axis at all ages (upper- and lower-right quadrants in **[Fig. 3](#F3){ref-type="fig"}A** and upper- and lower-left quadrants in [Fig. 3](#F3){ref-type="fig"}B), which demonstrates a positive association between these T cell markers. In contrast, the proportions of memory CD45RO- or CCR4-expressing T cells were projected on the opposite side of the *x*-axis (upper- and lower-left quadrants and upper- and lower-right quadrants in [Fig. 3](#F3){ref-type="fig"}A and B, respectively), demonstrating an inverse relationship between the proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ and the proportion of CD45RO- or CCR4-expressing CD4^+^ T cells. We observed the same relationships when investigating the association between FOXP3^+^ or CTLA-4^+^ T~regs~ within the CD25^high^ T cell population and the naïve or memory CD4^+^ T cells (Supplemental Fig. 2). Taken together, a high fraction of FOXP3^+^ or CTLA-4^+^ T~regs~, within the CD4^+^CD25^+^ or CD4^+^CD25^high^ T cell populations, was associated with a high proportion of naïve CD4^+^ T cells in the circulation during the first 36 months of life.

![Relationship between FOXP3^+^ or CTLA-4^+^ T~regs~ and expression of memory markers and homing receptors on CD4^+^ T cells in blood during infancy.\
PCA plot showing an overview of the data, including percentage of FOXP3^+^ (A) and CTLA-4^+^ T~regs~ (B) within the CD4^+^CD25^+^ T cells and the fraction of CD4^+^ T cells expressing CD45RA and CD45RO at birth, 3--5 days, and 1, 4, 18, and 36 months and HLA-DR, α~4~β~7~, CD62L, or CCR4 at birth and 4, 18, and 36 months of age.](zgb9990955070003){#F3}

High proportions of FOXP3^+^ or CTLA-4^+^ T~regs~ early in life are associated with a low proportion of CD4^+^ T cells with a memory phenotype later in infancy
---------------------------------------------------------------------------------------------------------------------------------------------------------------

As the proportions of FOXP3^+^ or CTLA-4^+^ T~regs~ were positively associated with naïve T cells and inversely correlated with memory T cells within the CD4^+^ T cell fraction, we performed OPLS to examine the X variables that displayed the strongest association (positive or negative) with a high proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ at the different ages. As shown in the representative OPLS loading column plots (**[Figs. 4](#F4){ref-type="fig"}A** and **[5](#F5){ref-type="fig"}A**), X variables lying in the same direction as FOXP3^+^ or CTLA-4^+^ T~regs~ within the CD25^+^ T cell population at 4 months of age (located to the far left) were positively associated (CD45RA, α~4~β~7~, and CD62L at 4, 18, and 36 months of age), whereas variables in the opposite direction were inversely correlated (CD45RO, HLA-DR, and CCR4 at 4, 18, and 36 months of age). The larger the bar and smaller the error bar in the OPLS loading column plot, the larger and more certain is the contribution to the model. Similar associations were observed for FOXP3^+^ or CTLA-4^+^ T~regs~ and the X variables in the OPLS analyses at birth, 3--5 days, and 1 and 18 months of age ([Figs. 4](#F4){ref-type="fig"}F--I and [5](#F5){ref-type="fig"}F--I, respectively).

![Correlations between FOXP3^+^ T~regs~ and expression of homing receptors and memory markers during infancy.\
OPLS was used to correlate the data matrices, X (the expression of CD45RA, CD45RO, α~4~β~7~, CD62L, or CCR4 on CD4^+^ T cells at 4, 18, and 36 months of age) and Y (FOXP3^+^ of CD4^+^CD25^+^ T cells), to each other by a linear multivariate model. X parameters lying in the same direction as FOXP3^+^ T~regs~ in the OPLS plots are positively associated, whereas parameters in the opposite direction are inversely correlated. Each column displays uncertainty bars with 95% confidence interval. (A) OPLS plot of the population of FOXP3^+^ T~regs~ at 4 months of age and the X variables. (B--E) Univariate correlations between the fraction of FOXP3^+^ T~regs~ at 4 months and the percentage of CD45RA^+^ (B and D) and CD45RO^+^ (C and E) on CD4^+^ T cells at 4 months (B and C) or 36 months (D and E) of age. (F--I) OPLS plots of the proportions of FOXP3^+^ T~regs~ at birth (F), 3--5 days (G), 1 month (H), and 18 months (I) of age and the X variables. (B--E) *P* ≤ 0.05 is considered significant (Spearman′s rank correlation test). (F--I) \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001, according to univariate analyses (Spearman′s rank correlation test) of the correlation between the proportion of FOXP3^+^ T~regs~ and the percentages of the X variables.](zgb9990955070004){#F4}

![Correlations between CTLA-4^+^ T~regs~ and expression of homing receptors and memory markers during infancy.\
OPLS was used to correlate the data matrices, X (the expression of CD45RA, CD45RO, α~4~β~7~, CD62L, or CCR4 on CD4^+^ T cells at 4, 18, and 36 months of age) and Y (CTLA-4^+^ of CD4^+^CD25^+^ T cells), to each other by a linear multivariate model. X parameters lying in the same direction as CTLA-4^+^ T~regs~ in the OPLS plots are positively associated, whereas parameters in the opposite direction are inversely correlated. Each column displays uncertainty bars with 95% confidence interval. (A) OPLS plot of the population of CTLA-4^+^ T~regs~ at 4 months of age and the X variables. (B--E) Univariate correlations between the fraction of CTLA-4^+^ T~regs~ at 4 months and the percentage of CD45RA^+^ (B and D) and CD45RO^+^ (C and E) on CD4^+^ T cells at 18 months (B and C) or 36 months (D and E) of age. (F--I) OPLS plots of the proportions of CTLA-4^+^ T~regs~ at birth (F), 3--5 days (G), 1 month (H), and 18 months (I) of age and the X variables. (B--E) *P* ≤ 0.05 is considered significant (Spearman′s rank correlation test). (F--I) \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001, according to univariate analyses (Spearman′s rank correlation test) of the correlation between the proportion of CTLA-4^+^ T~regs~ and the percentages of the X variables.](zgb9990955070005){#F5}

Univariate correlation analyses were performed for the proportions of FOXP3^+^ or CTLA-4^+^ T~regs~ and the memory and homing markers that displayed large bars with error bars not crossing the *x*-axis in the OPLS analyses ([Figs. 4](#F4){ref-type="fig"}A and F--I and [5](#F5){ref-type="fig"}A and F--I). In particular, the fraction of FOXP3^+^ T~regs~ at 4 months correlated positively to the percentage of CD4^+^ T cells expressing CD45RA and negatively to CD45RO at 36 months of age ([Fig. 4](#F4){ref-type="fig"}D and E). The percentage of CTLA-4^+^ T~regs~ at 4 months was positively correlated to the proportions of CD4^+^ T cells expressing CD45RA at 18 and 36 months of age ([Fig. 5](#F5){ref-type="fig"}B and D). However, CTLA-4^+^ T~regs~ at 4 months of age did not correlate significantly with the fraction of CD4^+^ T cells that expressed CD45RO at 18 and 36 months of age ([Fig. 5](#F5){ref-type="fig"}C and E). Moreover, a high fraction of FOXP3^+^ or CTLA-4^+^ T~regs~ at birth, 3--5 days, and 1 and 18 months also correlated positively or negatively with the proportions of either or both CD45RA and CD45RO at 4, 18, and 36 months of age ([Figs. 4](#F4){ref-type="fig"}F--I and [Fig. 5](#F5){ref-type="fig"}F--I). In summary, infants with a high proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ early in life had a low proportion of memory T cells later in life, which indicates that FOXP3^+^ or CTLA-4^+^ T~regs~ may modulate the proportion of CD4^+^ memory T cells later in infancy.

We recently showed that CD25^+^ T cells undergo homing receptor switch, i.e., from being α~4~β~7~-positive to being CCR4-positive, during their differentiation to a memory CD45RO phenotype \[[@B26]\]. Accordingly, the proportion of FOXP3^+^ T~regs~ at 4 months was inversely correlated to CCR4^+^ T cells at 4 and 36 months of age (*r*=--0.28, *P*=0.04, and *r*=--0.44, *P*=0.006, respectively). The α~4~β~7~ expression at 4 and 18 months correlated positively (*r*=0.50, *P*=0.001, and *r*=0.40, *P*=0.01, respectively) with FOXP3^+^ T~regs~ at birth. Furthermore, the proportion of CTLA-4^+^ T~regs~ at 4 months was inversely correlated to the expression of CCR4 on CD4^+^ T cells at 4, 18, and 36 months of age (*r*=--0.36, *P*=0.01; *r*=--0.32, *P*=0.04; and *r*=--0.35, *P*=0.05, respectively). Taken together, within the circulating CD25^+^ T cell population, a high proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ might modulate homing receptor switch on CD4^+^ T cells later in infancy.

DISCUSSION
==========

FOXP3^+^ T~regs~ and CTLA-4^+^ T cells are important immune regulators in mice and in humans \[[@B12]--[@B14]\]. In adults, T cells expressing these markers suppress in vitro proliferation \[[@B12], [@B13]\], and it was shown recently that CTLA-4^+^ T cells also possess the ability to prevent autoantigen-specific T cell migration into target tissues in mice \[[@B14], [@B17]\]. These observations led us to investigate the relationships between the proportions of FOXP3^+^ or CTLA-4^+^ T~regs~ of CD25^+^ T cells and naïve, memory, and homing receptors expressed on CD4^+^ T cells during early childhood using a prospective cohort study design. We show here for the first time that a high proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ in early infancy is associated with a low fraction of memory T cells expressing CD45RO later in childhood using multivariate factor analysis. Moreover, a high proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ was also found to be associated with a low proportion of CD4^+^ T cells that expresses the skin homing receptor CCR4. Accordingly, it has been demonstrated that upon TCR stimulation, the newly activated T cells up-regulate CCR4 in adults \[[@B28]\], and we recently showed that CCR4 expression is linked to the T cell memory phenotype in infants \[[@B26]\].

Several studies have demonstrated that CCR4-expressing Th2 cells are implicated in the development of allergic asthma and dermatitis \[[@B29]--[@B31]\], and blocking the CCR4 pathway results in hindered trafficking of activated T cells to their target tissue, leading to attenuated allergic inflammation \[[@B29]\]. Homing receptors involved in human autoimmune disorders remain to be elucidated, but in mice, CTLA-4-expressing T cells prevent tissue-specific T cell migration via yet-unclear immunological mechanisms \[[@B14], [@B17]\]. Thus, our results that indicate that T~regs~ modulate T cell activation, including homing receptor switch, could be of importance for explaining what factors mediate protection from inflammatory disease later in life. Indeed, lack of FOXP3^+^ T~regs~ or CTLA-4^+^ T cells is linked to various allergy- and autoimmune-related inflammatory conditions \[[@B7], [@B8], [@B15], [@B16]\].

The immunological mechanisms by which FOXP3^+^ or CTLA-4^+^ T~regs~ may regulate T cell maturation in vivo in infants remain speculative. However, APCs, i.e., DCs, have been implicated as a target for T~reg~ immune regulation in mice and humans \[[@B32], [@B33]\]. FOXP3^+^ T~regs~ express the adhesion molecule LFA-1, which permits aggregation with DCs to a higher degree than naïve T cells and may thus out-compete these cells from interacting with the APCs \[[@B33]\]. Regarding CTLA-4, it has been shown that its interaction with the costimulatory molecules CD80 and/or CD86 on DCs inhibits the accumulation of the primary T cell growth factor IL-2 \[[@B34]\]. Furthermore, CTLA-4 per se, independently of in which cell type it is expressed, down-regulates CD80 and/or CD86 on DCs \[[@B12], [@B33], [@B35]\] by binding and removing these molecules via transendocytosis, which will inhibit T cell activation and differentiation \[[@B18]\]. Moreover, blocking the interaction between CTLA-4 and CD80 and/or CD86 has been shown to expand the activated T cell population \[[@B36]\]. This is in accordance with our results in infants, showing that a high proportion of not only FOXP3^+^ T~regs~ but also CTLA-4^+^ T~regs~ is associated to a low fraction of memory T cells.

In our hands, it was not possible to elucidate whether FOXP3 and CTLA-4 are coexpressed on the same cells using flow cytometry. We found that intracellular double-staining for FOXP3 and CTLA-4 leads to suboptimal gating strategies, as the two intracellular markers influence each other. Accordingly, it was demonstrated recently that staining for more than one intracellular marker will quench other fluorochromes used \[[@B37]\]. Thus, in present study, data obtained from double-stained samples were not comparable with those obtained from samples stained with FOXP3 or CTLA-4 alone. Staining for CD25 and CD127 to identify T~regs~ \[[@B38]\] and study their expression of CTLA-4 in infants could have been a better approach. Unfortunately, the importance of CD127 to human T~reg~ identification was not discovered when initiating the present prospective cohort study.

In conclusion, a high proportion of FOXP3^+^ or CTLA-4^+^ T~regs~ in early infancy is associated with a low fraction of memory T cells expressing CD45RO and CCR4 later in childhood. We suggest that FOXP3^+^ and CTLA-4^+^ T~regs~ possess immunoregulatory properties in vivo in infants, which may reduce activation and tissue trafficking of T cells.
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